Fosun Pharma to acquire 74% stake in Gland Pharma for $1.09 billion
This is in sharp reduction to the previous agreement of "paying no more than USD 50 million contingent consideration for Gland Pharma's Enoxaparin sales in the US market".
Sep 18, 2017, 18:01 PM IST
Doklam effect? India raises concerns around Chinese firm Fosun's takeover of Gland Pharma
The deal has won the approval of the Competition Commission of India (CCI) and India`s Foreign Investment Promotion Board (FIPB) in the last few months, but some in the government have expressed concerns, the source said, declining to be named.
Aug 01, 2017, 20:14 PM IST
